MMP2 as an independent prognostic stratifier in oral cavity cancers

MMP2 as an independent prognostic stratifier in oral cavity cancers

Background Around 25% of oral cavity squamous cell carcinoma (OCSCC) are not controlled by the standard of care, but there is currently no validated biomarker to identify those patients. Our objective was to determine a robust biomarker for severe OCSCC, using a biology-driven strategy. Patients and...

Full description

Bibliographic Details
Main Authors: Caroline Hoffmann, Sophie Vacher, Philémon Sirven, Charlotte Lecerf, Lucile Massenet, Aurélie Moreira, Aurore Surun, Anne Schnitzler, Jerzy Klijanienko, Odette Mariani, Emmanuelle Jeannot, Nathalie Badois, Maria Lesnik, Olivier Choussy, Christophe Le Tourneau, Maude Guillot-Delost, Maud Kamal, Ivan Bieche, Vassili Soumelis
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
biomarker
metalloproteinase
prognosis
secretome
squamous cell carcinoma
head and neck
oral cavity
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1754094

Internet

http://dx.doi.org/10.1080/2162402X.2020.1754094

Similar Items